<DOC>
	<DOCNO>NCT00982137</DOCNO>
	<brief_summary>The purpose study obtain safety , tolerability , immunogenicity data co-administration sequential administration Chimeravax™-JE vaccine STAMARIL® . Objectives : Safety : - Obtain safety tolerability data single , fix dose ChimeriVax™-JE administer concurrently , one month one month STAMARIL® adult volunteer ( ≥ 18 ≤ 55 year ) without prior Japanese encephalitis ( JE ) yellow fever ( YF ) vaccination . Immunogenicity : - Obtain data antibody response single , fix dose ChimeriVax™-JE administer concurrently , one month one month STAMARIL® adult volunteer without prior JE ( YF ) vaccination . - Assess durability immune response adult volunteer 6 month administration ChimeriVax™-JE STAMARIL® .</brief_summary>
	<brief_title>Study Live Attenuated Japanese Encephalitis Vaccine ( ChimeriVax™-JE ) Yellow Fever Vaccine ( STAMARIL® )</brief_title>
	<detailed_description>All participant receive two injection , one arm Days 0 30 , respectively . Immunogenicity test Days 0 , 15 , 30 , 45 , 60 , Month 6 .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Yellow Fever</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : All aspect protocol explain write informed consent obtain participant . Aged ≥ 18 ≤ 55 year Day 0 . In good general health , without significant medical history , physical examination finding , clinically significant abnormal laboratory result . Participant must available study duration , include plan followup visit . The participant must agree take follow precaution avoid insect bite 7 day follow vaccination : ( ) wear longsleeved shirt trouser ; ( b ) apply N , NDiethylmetatoluamide ( DEET ) contain insect repellent ; ( c ) sleep screen enclosure . Female participant childbearing potential must negative serum pregnancy test . An efficacious hormonal method ( i.e. , oral , implantable injectable ) contraception intrauterine contraceptive device ( IUCD ) must use least 1 month Screening least 1 month Day 60 . These participant sign agreement contraception practise specify period specify method use . Female participant unable become pregnant must document ( e.g. , tubal ligation hysterectomy ) . Exclusion Criteria : A history flavivirus infection vaccination Japanese encephalitis ( JE ) yellow fever ( YF ) . Previous vaccination determine history ( interview subject ) and/or review participant 's vaccination card official documentation ( either history documentation vaccination fulfil criterion exclusion ) . Impaired immunity , include know suspected immunodeficiency ( e.g. , human immunodeficiency virus [ HIV ] infection , primary immunodeficiency disorder , leukemia , lymphoma ) , use immunosuppressive antineoplastic drug ( include corticosteroid &gt; 10 mg prednisone , equivalent , 14 day last three month ) . Clinically significant abnormal laboratory assessment result . Serious adverse reaction characterise urticaria angioedema prior vaccine , chicken egg egg protein . Transfusion blood treatment blood product , include intramuscular intravenous serum globulin , within six month Screening Visit Day 60 . Administration another vaccine within 28 day receive study vaccination . Physical examination indicate clinically significant medical condition include shortlived longstanding illness become severe . Body temperature &gt; 38.1°C ( 100.6°F ) acute illness within 3 day prior inoculation ( participant may reschedule ) . Intention travel area prior study visit Day 60 . Seropositive hepatitis C virus ( HCV ) HIV positive hepatitis B virus ( HBV ) ( antigen ) . Lactation intend pregnancy female participant . Excessive alcohol consumption , drug abuse , significant psychiatric illness . A know suspected physiological structural condition compromise integrity bloodbrain barrier ( e.g. , significant hypertensive cerebrovascular disease , trauma , ischaemia , infection , inflammation brain ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Japanese Encephalitis</keyword>
	<keyword>Yellow Fever</keyword>
	<keyword>ChimeriVax™-JE</keyword>
	<keyword>STAMARIL®</keyword>
	<keyword>Adult</keyword>
</DOC>